[Cost-effectiveness evaluation of Nirmatrelvir plus ritonavir (Paxlovid)]

Record ID 32018013898
Japanese
Details
Project Status: Ongoing
URL for project: https://c2h.niph.go.jp/
Anticipated Publish Date: 2026
English language abstract: There is no English language summary available
Publication Type: Not Assigned
Country: Japan
MeSH Terms
  • COVID-19
  • COVID-19 Drug Treatment
  • SARS-CoV-2
  • Cost-Effectiveness Analysis
  • Antiviral Agents
  • Ritonavir
  • Drug Combinations
Contact
Organisation Name: Center for Outcomes Research and Economic Evaluation for Health
Contact Address: 2-3-6 Minami, Wako-shi, Saitama 351-0197 Japan
Contact Name: Takeru Shiroiwa
Contact Email: t.shiroiwa@gmail.com
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.